# The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006, Regulation 22: Amendment of regulation 42 of the principal Regulations


For regulation 42 of the principal Regulations (obligations of manufacturing authorisation holder), substitute—
“42 The holder of a manufacturing authorisation shall—
(a) comply with the principles and guidelines of good manufacturing practice;
(b) comply with the provisions referred to in regulation 40(3);
(c) allow the licensing authority access to his premises at any reasonable time; and
(d) put and keep in place arrangements which enable the qualified person to carry out his duties, including placing at his disposal all the necessary facilities.”.

---
Source: https://www.legislation.gov.uk/uksi/2006/1928/regulation/22 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-regulations-2006/regulation-22
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.